Ghrelin agonist JMV 1843 increases food intake, body weight and expression of orexigenic neuropeptides in mice

Physiological Research

Volumn 62, Issue 4, 2013, Pages 435-444

  Holubova M ^a   Spolcova A ^a   Demianova Z ^a   Sykora D ^b   Fehrentz, J A ^c   Martinez, J ^c   Stofkova A ^d   Jurcovicova J ^d   Drapalova J ^d   Lacinova Z ^d   Haluzik M ^d   Zelezna B ^a   Maletinska L ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c UNIVERSITÉ DE MONTPELLIER   (France)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Food intake; GHS R agonists; JMV 1843; Male C57BL 6 mice; NPY AgRP

Indexed keywords

AGOUTI RELATED PROTEIN; AGRP PROTEIN, RAT; AIB TRP GTRP CHO; AIB-TRP-GTRP-CHO; APPETITE STIMULANT; GHRELIN; GHRELIN RECEPTOR; ION CHANNEL; MESSENGER RNA; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; NEUROPEPTIDE Y; OLIGOPEPTIDE;

ANIMAL; ARTICLE; BROWN ADIPOSE TISSUE; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EATING; GENETICS; HYPOTHALAMUS; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION; UPREGULATION; WEIGHT GAIN;

ADIPOSE TISSUE, BROWN; AGOUTI-RELATED PROTEIN; ANIMALS; APPETITE STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; GHRELIN; HYPOTHALAMUS; INJECTIONS, SUBCUTANEOUS; ION CHANNELS; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; NEUROPEPTIDE Y; OLIGOPEPTIDES; RECEPTORS, GHRELIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION; WEIGHT GAIN;

EID: 84883546187     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. AKAMIZU T, KANGAWA K: Translational research on the clinical applications of ghrelin. Endocr J 53: 585-591, 2006.
2. BILLINTON CJ, BRIGGS JE, HARKER S, GRACE M, LEVINE AS: Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 266: R1765-R1770, 1994.
3. BROGLIO F, BOUTIGNON F, BENSO A, GOTTERO C, PRODAM F, ARVAT E, GHÉ C, CATAPANO F, TORSELLO A, LOCATELLI V, MUCCIOLI G, BOEGLIN D, GUERLAVAIS V, FEHRENTZ JA, MARTINEZ J, GHIGO E, DEGHENGHI R: EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. J Endocrinol Invest 25: RC26-RC28, 2002.
4. CHEN HY, TRUMBAUER ME, CHEN AS, WEINGARTH DT, ADAMS JR, FRAZIER EG, SHEN Z, MARSH DJ, FEIGHNER SD, GUAN XM, YE Z, NARGUND RP, SMITH RG, VAN DER PLOEG LH, HOWARD AD, MACNEIL DJ, QIAN S: Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agoutirelated protein. Endocrinology 145: 2607-2612, 2004.
5. CLAPHAM JC: Central control of thermogenesis. Neuropharmacology 63: 111-123, 2012.
6. COWLEY MA, SMITH RG, DIANO S, TSCHÖP M, PRONCHUK N, GROVE KL, STRASBURGER CJ, BIDLINGMAIER M, ESTERMAN M, HEIMAN ML, GARCIA-SEGURA LM, NILLNI EA, MENDEZ P, LOW MJ, SOTONYI P, FRIEDMAN JM, LIU H, PINTO S, COLMERS WF, CONE RD, HORVATH TL: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37: 649-661, 2003.
7. DEBOER MD, ZHU X, LEVASSEUR PR, INUI A, HU Z, HAN G, MITCH WE, TAYLOR JE, HALEM HA, DONG JZ, DATTA R, CULLER MD, MARKS DL: Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 149: 827-835, 2008.
8. GUERLAVAIS V, BOEGLIN D, MOUSSEAUX D, OIRY C, HEITZ A, DEGHENGHI R, LOCATELLI V, TORSELLO A, GHÉ C, CATAPANO F, MUCCIOLI G, GALLEYRAND JC, FEHRENTZ JA, MARTINEZ J: New active series of growth hormone secretagogues. J Med Chem 46: 1191-1203, 2003.
9. HATZIIEREMIA S, KOSTOMITSOPOULOS N, BALAFAS V, TAMVAKOPOULOS C: A liquid chromatographic/ tandem mass spectroscopic method for quantification of the cyclic peptide melanotan-II. Plasma and brain tissue concentrations following administration in mice. Rapid Commun Mass Spectrom 21: 2431-2438, 2007.
10. KAMEGAI J, TAMURA H, SHIMIZU T, ISHII S, SUGIHARA H, WAKABAYASHI I: Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 50: 2438-2443, 2001.
11. KIM MS, NAMKOONG C, KIM HS, JANG PG, KIM PAK YM, KATAKAMI H, PARK JY, LEE KU: Chronic central administration of ghrelin reverses the effects of leptin. Int J Obes Relat Metab Disord 28: 1264-1271, 2004.
12. KOJIMA M, HOSODA H, DATE Y, NAKAZATO M, MATSUO H, KANGAWA K: Ghrelin is a growth-hormonereleasing acylated peptide from stomach. Nature 402: 656-660, 1999.
13. MALETÍNSKÁ L, MATYŠKOVÁ R, MAIXNEROVÁ J, SÝKORA D, PÝCHOVÁ M, SPOLCOVÁ A, BLECHOVÁ M, DRÁPALOVÁ J, LACINOVÁ Z, HALUZÍK M, ZELEZNÁ B: The Peptidic GHS-R antagonist [D-Lys(3)]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity. Mol Cell Endocrinol 343: 55-62, 2011.
14. MALETÍNSKÁ L, PÝCHOVÁ M, HOLUBOVÁ M, BLECHOVÁ M, DEMIANOVÁ Z, ELBERT T, ŽELEZNÁ B: Characterization of new stable ghrelin analogs with prolonged orexigenic potency. J Pharmacol Exp Ther 340: 781-786, 2012.
15. MOUSSEAUX D, LE GALLIC L, RYAN J, OIRY C, GAGNE D, FEHRENTZ JA, GALLEYRAND JC, MARTINEZ J: Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway. Br J Pharmacol 148: 350-365, 2006.
16. NAKAZATO M, MURAKAMI N, DATE Y, KOJIMA M, MATSUO H, KANGAWA K, MATSUKURA S: A role for ghrelin in the central regulation of feeding. Nature 409: 194-198, 2001.
17. PALUS S, SCHUR R, AKASHI YJ, BOCKMEYER B, DATTA R, HALEM H, DONG J, CULLER MD, ADAMS V, ANKER SD, SPRINGER J: Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model. PLoS One 6: e26865, 2011.
18. PICCOLI F, DEGEN L, MACLEAN C, PETER S, BASELGIA L, LARSEN F, BEGLINGER C, DREWE J: Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects. J Clin Endocrinol Metab 92: 1814-1820, 2007.
19. PIRNIK Z, BUNDZIKOVÁ J, HOLUBOVÁ M, PÝCHOVÁ M, FEHRENTZ JA, MARTINEZ J, ŽELEZNÁ B, MALETÍNSKÁ L, KISS A: Ghrelin agonists impact on Fos protein expression in brain areas related to food intake regulation in male C57BL/6 mice. Neurochem Int 59: 889-895, 2011.
20. SMALL CJ, KIM MS, STANLEY SA, MITCHEL JR, MURPHY K, MORGAN DG, GHATEI MA, BLOOM SR: Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 50: 248-254, 2001.
21. STOFKOVA A, ZELEZNA B, ROMZOVA M, ULICNA O, KISS A, SKURLOVA M, JURCOVICOVA J: Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats. Mediators Inflamm 2010, article ID 398026, 2010.
22. STRASSBURG S, ANKER SD, CASTANEDA TR, BURGET L, PEREZ-TILVE D, PFLUGER PT, NOGUEIRAS R, HALEM H, DONG JZ, CULLER MD, DATTA R, TSCHÖP MH: Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am J Physiol Endocrinol Metab 295: E78-E84, 2008.
23. TSCHÖP M, SMILEY DL, HEIMAN ML: Ghrelin induces adiposity in rodents. Nature 407: 908-913, 2000.
24. TSUBONE T, MASAKI T, KATSURAGI I, TANAKA K, KAKUMA T, YOSHIMATSU H: Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept 130: 97-103, 2005.